Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Metric Says You Are Smart to Sell Vertex Pharmaceuticals Incorporated (VRTX)

Page 1 of 2

Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the right investment to pursue these days? The smart money is getting less optimistic. The number of bullish hedge fund bets fell by 5 in recent months.

In today’s marketplace, there are dozens of gauges market participants can use to watch stocks. Some of the most useful are hedge fund and insider trading interest. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the best money managers can beat the broader indices by a solid margin (see just how much).

Vertex Pharmaceuticals IncorporatedJust as key, bullish insider trading activity is a second way to break down the financial markets. Obviously, there are a variety of incentives for an executive to cut shares of his or her company, but just one, very clear reason why they would initiate a purchase. Several academic studies have demonstrated the market-beating potential of this tactic if shareholders know where to look (learn more here).

Keeping this in mind, we’re going to take a peek at the latest action encompassing Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).

How have hedgies been trading Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)?

In preparation for this quarter, a total of 22 of the hedge funds we track were bullish in this stock, a change of -19% from one quarter earlier.

Because Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has witnessed falling interest from hedge fund managers, it’s safe to say that there is a sect of funds that slashed their full holdings last quarter. Interestingly, Arthur B Cohen and Joseph Healey’s Healthcor Management LP sold off the largest stake of all the hedgies we monitor, worth close to $15.7 million in stock.. Jacob Gottlieb’s fund, Visium Asset Management, also dropped its stock, about $14.7 million worth. These bearish behaviors are interesting, as aggregate hedge fund interest was cut by 5 funds last quarter.

Insider trading activity in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Insider buying is most useful when the company in question has experienced transactions within the past six months. Over the last 180-day time period, Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has seen zero unique insiders purchasing, and 7 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). These stocks are Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX), Illumina, Inc. (NASDAQ:ILMN), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), and Regeneron Pharmaceuticals Inc (NASDAQ:REGN). This group of stocks are in the biotechnology industry and their market caps match VRTX’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!